Symbols / CYPH Stock $0.92 -7.51% Cypherpunk Technologies Inc.

Financial Services • Asset Management • United States • NCM
CYPH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Financial Services
Industry Asset Management
CEO Mr. Douglas E. Onsi J.D.
Exch · Country NCM · United States
Market Cap 83.22M
Enterprise Value 69.23M
Income 4.82M
Sales —
FCF (ttm) -174.60M
Book/sh 1.83
Cash/sh 0.16
Employees 6
Insider 10d —
IPO Jan 25, 2017
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 13.21
Forward P/E —
PEG —
P/S —
P/B 0.51
P/C —
EV/EBITDA -1.89
EV/Sales —
Quick Ratio 35.55
Current Ratio 35.56
Debt/Eq 0.03
LT Debt/Eq —
EPS (ttm) 0.07
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-13
Earnings (prior) 2025-11-12
ROA -21.61%
ROE 5.11%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 89.98M
Shs Float 72.63M
Insider Own 8.70%
Instit Own 19.54%
Short Float 13.00%
Short Ratio 4.30
Short Interest 10.02M
52W High 3.70
vs 52W High -75.00%
52W Low 0.23
vs 52W Low 298.66%
Beta -0.22
Impl. Vol. 6.25%
Rel Volume 0.72
Avg Volume 2.25M
Volume 1.62M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.00
Price $0.92
Change -7.51%
About

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.92
Latest analyst target
3. DCF / Fair value
$-34.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.92
Low
—
High
—
Mean
—
News
RSS: Latest CYPH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-26 MIRABELLI CHRISTOPHER K Director — 60,000 $0.71 $42,630
2026-03-13 CAVANAUGH JAMES H Director — 168,750 — —
2026-03-13 MIRABELLI CHRISTOPHER K Director — 168,750 — —
2026-03-13 LI WILLIAM W. M.D. Director — 168,750 — —
2026-03-13 LOSCALZO JOSEPH Director — 168,750 — —
2026-03-13 MASHIACH NISSIM Director — 168,750 — —
2026-03-13 DIETZ THOMAS JOHN Director — 104,500 — —
2026-03-13 RICHARD CHRISTIAN M Director — 168,750 — —
2026-03-13 MARTIN PATRICIA A Director — 168,750 — —
2026-03-13 SCHILSKY RICHARD L. M.D. Director — 168,750 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
36.70
-47.62%
70.06
-18.48%
85.94
+57.08%
54.71
Research And Development
25.67
-55.13%
57.21
-21.88%
73.23
+62.87%
44.97
Selling General And Administration
10.87
-15.38%
12.85
-6.96%
13.81
+17.03%
11.80
General And Administrative Expense
10.87
-15.38%
12.85
-6.96%
13.81
+17.03%
11.80
Other Gand A
10.87
-15.38%
12.85
-6.96%
13.81
+17.03%
11.80
Other Operating Expenses
0.16
—
-1.10
+46.32%
-2.05
Total Expenses
36.70
-47.62%
70.06
-18.48%
85.94
+57.08%
54.71
Operating Income
-36.70
+47.62%
-70.06
+18.48%
-85.94
-57.08%
-54.71
Total Operating Income As Reported
-41.07
+41.38%
-70.06
+19.51%
-87.04
-53.34%
-56.76
EBITDA
10.10
+115.08%
-66.97
+22.07%
-85.92
-58.01%
-54.38
Normalized EBITDA
-35.78
+46.53%
-66.92
+22.11%
-85.92
-59.80%
-53.77
Reconciled Depreciation
0.00
-100.00%
0.01
-66.67%
0.01
-6.25%
0.02
EBIT
10.10
+115.08%
-66.97
+22.07%
-85.94
-57.99%
-54.40
Total Unusual Items
45.88
+109342.86%
-0.04
-4100.00%
-0.00
+99.84%
-0.61
Total Unusual Items Excluding Goodwill
45.88
+109342.86%
-0.04
-4100.00%
-0.00
+99.84%
-0.61
Special Income Charges
-4.53
0.00
—
—
Restructuring And Mergern Acquisition
4.53
0.00
—
—
Net Income
4.82
+107.14%
-67.56
+17.02%
-81.41
-49.12%
-54.60
Pretax Income
10.08
+115.05%
-66.97
+17.74%
-81.41
-49.52%
-54.45
Net Non Operating Interest Income Expense
0.89
-71.49%
3.13
-22.30%
4.03
+362.34%
0.87
Interest Expense Non Operating
0.02
0.00
0.00
-100.00%
0.05
Net Interest Income
0.89
-71.49%
3.13
-22.30%
4.03
+362.34%
0.87
Interest Expense
0.02
0.00
0.00
-100.00%
0.05
Interest Income Non Operating
0.92
-70.73%
3.13
-22.30%
4.03
+335.35%
0.93
Interest Income
0.92
-70.73%
3.13
-22.30%
4.03
+335.35%
0.93
Other Income Expense
45.88
+109342.86%
-0.04
-108.42%
0.50
+182.07%
-0.61
Other Non Operating Income Expenses
—
—
0.50
—
Gain On Sale Of Security
50.41
+120121.43%
-0.04
-4100.00%
-0.00
+99.84%
-0.61
Tax Provision
5.25
+798.29%
0.58
0.00
-100.00%
0.15
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
9.64
+109342.86%
-0.01
0.00
0.00
Net Income Including Noncontrolling Interests
4.82
+107.14%
-67.56
+17.02%
-81.41
-49.12%
-54.60
Net Income From Continuing Operation Net Minority Interest
4.82
+107.14%
-67.56
+17.02%
-81.41
-49.12%
-54.60
Net Income From Continuing And Discontinued Operation
4.82
+107.14%
-67.56
+17.02%
-81.41
-49.12%
-54.60
Net Income Continuous Operations
4.82
+107.14%
-67.56
+17.02%
-81.41
-49.12%
-54.60
Normalized Income
-31.42
+53.46%
-67.52
+17.06%
-81.41
-50.80%
-53.99
Net Income Common Stockholders
4.82
+107.11%
-67.79
+16.74%
-81.41
-49.12%
-54.60
Otherunder Preferred Stock Dividend
0.00
-100.00%
0.23
0.00
—
Diluted EPS
—
-1.81
+54.52%
-3.98
+17.08%
-4.80
Basic EPS
—
-1.81
+54.52%
-3.98
+17.08%
-4.80
Basic Average Shares
—
37.55
+83.67%
20.45
+80.55%
11.32
Diluted Average Shares
—
37.55
+83.67%
20.45
+80.55%
11.32
Diluted NI Availto Com Stockholders
4.82
+107.11%
-67.79
+16.74%
-81.41
-49.12%
-54.60
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
163.18
+232.18%
49.12
-32.55%
72.83
+3.51%
70.35
Current Assets
162.08
+237.39%
48.04
-32.90%
71.60
+5.37%
67.95
Cash Cash Equivalents And Short Term Investments
14.04
-70.30%
47.25
-33.12%
70.64
+7.85%
65.50
Cash And Cash Equivalents
14.04
-70.30%
47.25
-33.12%
70.64
+7.85%
65.50
Receivables
148.01
+20923.58%
0.70
-8.69%
0.77
-63.27%
2.10
Other Receivables
148.01
+20923.58%
0.70
-8.69%
0.77
-63.27%
2.10
Prepaid Assets
—
—
—
—
Other Current Assets
0.04
-53.49%
0.09
-53.01%
0.18
-47.86%
0.35
Total Non Current Assets
1.10
+1.01%
1.09
-11.24%
1.23
-48.90%
2.40
Net PPE
0.04
-85.77%
0.27
+1.91%
0.26
-61.97%
0.69
Gross PPE
0.26
-45.90%
0.49
+1.04%
0.48
-46.03%
0.90
Accumulated Depreciation
-0.23
-2.26%
-0.22
+0.00%
-0.22
-7.28%
-0.21
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.08
+0.00%
0.08
+0.00%
0.08
+0.00%
0.08
Other Properties
0.08
+0.00%
0.08
+0.00%
0.08
+0.00%
0.08
Leases
0.11
-67.67%
0.33
+1.53%
0.33
-55.83%
0.74
Non Current Deferred Assets
0.40
0.00
0.00
-100.00%
0.58
Non Current Deferred Taxes Assets
—
—
—
0.00
Non Current Prepaid Assets
0.66
-19.56%
0.82
-14.80%
0.97
-12.82%
1.11
Other Non Current Assets
—
—
—
0.03
Total Liabilities Net Minority Interest
9.68
-31.26%
14.08
+10.97%
12.68
+10.42%
11.49
Current Liabilities
4.56
-67.62%
14.08
+10.97%
12.68
+13.00%
11.22
Payables And Accrued Expenses
3.06
-77.85%
13.81
+11.17%
12.42
+14.92%
10.81
Payables
2.45
-53.49%
5.27
-18.42%
6.46
+14.28%
5.66
Accounts Payable
1.98
-58.23%
4.74
-26.64%
6.46
+14.28%
5.66
Current Accrued Expenses
0.61
-92.90%
8.54
+43.29%
5.96
+15.63%
5.15
Pensionand Other Post Retirement Benefit Plans Current
1.46
0.00
—
—
Total Tax Payable
0.47
-11.11%
0.53
0.00
—
Income Tax Payable
0.47
-11.11%
0.53
0.00
—
Current Debt And Capital Lease Obligation
0.04
-85.71%
0.27
+1.53%
0.26
-37.02%
0.42
Current Capital Lease Obligation
0.04
-85.71%
0.27
+1.53%
0.26
-37.02%
0.42
Total Non Current Liabilities Net Minority Interest
5.12
0.00
0.00
-100.00%
0.26
Long Term Debt And Capital Lease Obligation
—
—
0.00
-100.00%
0.26
Long Term Capital Lease Obligation
—
—
0.00
-100.00%
0.26
Non Current Deferred Liabilities
5.12
0.00
—
—
Non Current Deferred Taxes Liabilities
5.12
0.00
—
—
Preferred Securities Outside Stock Equity
—
—
0.00
0.00
Stockholders Equity
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Common Stock Equity
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Capital Stock
0.08
+121.05%
0.04
+46.15%
0.03
+160.00%
0.01
Common Stock
0.08
+121.05%
0.04
+46.15%
0.03
+160.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
83.85
+118.76%
38.33
+49.93%
25.57
+158.18%
9.90
Ordinary Shares Number
83.85
+118.76%
38.33
+49.93%
25.57
+158.18%
9.90
Additional Paid In Capital
616.22
+22.63%
502.50
+9.34%
459.59
+21.94%
376.90
Retained Earnings
-462.55
+1.03%
-467.37
-16.96%
-399.58
-25.59%
-318.17
Gains Losses Not Affecting Retained Earnings
-0.10
+20.83%
-0.12
-213.21%
0.11
-17.19%
0.13
Other Equity Adjustments
-0.10
+20.83%
-0.12
-213.21%
0.11
-17.19%
0.13
Total Equity Gross Minority Interest
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Total Capitalization
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Working Capital
157.52
+363.81%
33.96
-42.35%
58.91
+3.86%
56.73
Invested Capital
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Total Debt
0.04
-85.71%
0.27
+1.53%
0.26
-61.36%
0.68
Capital Lease Obligations
0.04
-85.71%
0.27
+1.53%
0.26
-61.36%
0.68
Net Tangible Assets
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Tangible Book Value
153.51
+337.99%
35.05
-41.72%
60.14
+2.17%
58.87
Other Equity Interest
-0.15
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-43.90
+27.19%
-60.30
-37.82%
-43.75
+10.79%
-49.04
Cash Flow From Continuing Operating Activities
-43.90
+27.19%
-60.30
-37.82%
-43.75
+10.79%
-49.04
Net Income From Continuing Operations
4.82
+107.14%
-67.56
+17.02%
-81.41
-49.12%
-54.60
Depreciation Amortization Depletion
0.00
-100.00%
0.01
-66.67%
0.01
-6.25%
0.02
Depreciation
0.00
-100.00%
0.01
-66.67%
0.01
-6.25%
0.02
Depreciation And Amortization
0.00
-100.00%
0.01
-66.67%
0.01
-6.25%
0.02
Other Non Cash Items
0.22
-46.02%
0.41
-98.62%
29.99
+7417.29%
0.40
Stock Based Compensation
4.90
-10.99%
5.50
+7.33%
5.13
-1.00%
5.18
Deferred Tax
5.12
0.00
—
—
Deferred Income Tax
5.12
0.00
—
—
Operating Gains Losses
-50.41
-120121.43%
0.04
+223.08%
0.01
-97.86%
0.61
Gain Loss On Investment Securities
-50.40
—
—
—
Net Foreign Currency Exchange Gain Loss
-0.01
-111.90%
0.04
+223.08%
0.01
-97.86%
0.61
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-8.56
-763.26%
1.29
-48.63%
2.51
+485.71%
-0.65
Change In Receivables
0.15
0.00
-100.00%
1.30
+229.04%
-1.01
Change In Prepaid Assets
1.02
+919.00%
0.10
-39.02%
0.16
-60.58%
0.42
Change In Payables And Accrued Expense
-10.52
-818.31%
1.46
+105.62%
0.71
-24.66%
0.94
Change In Payable
-10.52
-818.31%
1.46
+105.62%
0.71
—
Change In Account Payable
-10.42
-1255.32%
0.90
+26.69%
0.71
—
Change In Other Working Capital
—
—
—
0.15
Change In Other Current Assets
1.02
+613.29%
0.14
-80.88%
0.75
+199.07%
-0.76
Change In Other Current Liabilities
-0.23
+45.32%
-0.42
-0.48%
-0.41
-3.75%
-0.40
Investing Cash Flow
-97.00
0.00
-100.00%
48.97
0.00
Cash Flow From Continuing Investing Activities
-97.00
0.00
-100.00%
48.97
0.00
Net PPE Purchase And Sale
—
—
—
—
Purchase Of PPE
—
—
—
—
Sale Of PPE
—
—
—
—
Capital Expenditure
-97.00
—
—
—
Net Business Purchase And Sale
—
0.00
-100.00%
50.36
0.00
Net Intangibles Purchase And Sale
-97.00
0.00
—
—
Purchase Of Intangibles
-97.00
0.00
—
—
Net Other Investing Changes
—
—
-1.39
—
Financing Cash Flow
107.65
+189.50%
37.18
+124046.67%
-0.03
+85.71%
-0.21
Cash Flow From Continuing Financing Activities
107.65
+189.50%
37.18
+124046.67%
-0.03
+85.71%
-0.21
Net Common Stock Issuance
108.69
+171.74%
40.00
+4000000.00%
-0.00
0.00
Common Stock Payments
—
0.00
+100.00%
-0.00
0.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.00
0.00
Proceeds From Stock Option Exercised
0.02
-87.97%
0.13
+558.62%
-0.03
0.00
Net Other Financing Charges
-1.06
+63.98%
-2.95
—
-0.21
Changes In Cash
-33.25
-43.86%
-23.11
-545.72%
5.19
+110.53%
-49.25
Effect Of Exchange Rate Changes
0.04
+113.98%
-0.28
-548.84%
-0.04
+73.46%
-0.16
Beginning Cash Position
47.25
-33.12%
70.64
+7.85%
65.50
-43.00%
114.92
End Cash Position
14.04
-70.30%
47.25
-33.12%
70.64
+7.85%
65.50
Free Cash Flow
-140.90
-133.67%
-60.30
-37.82%
-43.75
+10.79%
-49.04
Change In Income Tax Payable
-0.10
-116.90%
0.56
0.00
—
Change In Tax Payable
-0.10
-116.90%
0.56
0.00
—
Common Stock Issuance
108.69
+171.74%
40.00
0.00
0.00
Issuance Of Capital Stock
108.69
+171.74%
40.00
0.00
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
Sale Of Business
—
0.00
-100.00%
50.36
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category